Langer, Florian; Gerlach, Horst E.; Schimke, Alexandra et al.
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practiceTHROMBOSIS RESEARCH. Bd. 220. 2022 S. 145-152
Hobohm, Lukas; Sagoschen, Ingo; Habertheuer, Andreas et al.
Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolismRESUSCITATION. Bd. 170. 2022 S. 285-292
Hu, Yong; Scharrer, Anke; Hau, Chi et al.
Coagulation signaling from amniotic fluid to fetal skinBLOOD ADVANCES. Bd. 6. H. 19. 2022 S. 5538-5541
Mailer, Reiner K.; Renne, Thomas
Commentary on "Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa": Small molecule factor XIa inhibitor asundexian allows for safer anticoagulation COMMENTJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 20. H. 6. 2022 S. 1309-1311
Aluia, M.; Kuntic, M.; Jurk, K. et al.
Conditional over-expression of heme-oxygenase 1 in myelomonocytic cells reduces hypertension and vascular inflammationEUROPEAN HEART JOURNAL. Bd. 43. 2022 S. 2223-2223
Farmakis, Ioannis T.; Barco, Stefano; Mavromanoli, Anna C. et al.
Cost-of-Illness Analysis of Long-Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE RegistryJOURNAL OF THE AMERICAN HEART ASSOCIATION. Bd. 11. H. 20. 2022
Farmakis, I.; Barco, S.; Mavromanoli, A. C. et al.
Cost-of-illness analysis of long-term healthcare resource utilization and disease burden in patients with pulmonary embolism: insights from the PREFER in VTE registryEUROPEAN HEART JOURNAL. Bd. 43. 2022 S. 1894-1894
Hobohm, L.; Sagoschen, I.; Barco, S. et al.
COVID-19 infection and its impact on case-fatality in patients with pulmonary embolismEUROPEAN HEART JOURNAL. Bd. 43. 2022 S. 1888-1888
Barco, Stefano; Schreiber, Karen
COVID-19: ACT trials for colchicine and antithrombotic therapiesLANCET RESPIRATORY MEDICINE. Bd. 10. H. 12. 2022 S. 1106-1108
Gorog, Diana A.; Storey, Robert F.; Gurbel, Paul A. et al.
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers ColloquiumNATURE REVIEWS CARDIOLOGY. Bd. 19. H. 7. 2022 S. 475-495